Vernalis plc (NASDAQ:VNLPY) has earned an average broker rating score of 3.00 (Hold) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a hold recommendation.

Zacks has also assigned Vernalis plc an industry rank of 119 out of 265 based on the ratings given to related companies.

Separately, Zacks Investment Research upgraded shares of Vernalis plc from a “sell” rating to a “hold” rating and set a $0.50 price target for the company in a report on Tuesday, June 6th.

COPYRIGHT VIOLATION WARNING: This news story was originally published by American Banking News and is owned by of American Banking News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/08/14/vernalis-plc-vnlpy-receives-consensus-recommendation-of-hold-from-brokerages.html.

Shares of Vernalis plc (NASDAQ:VNLPY) opened at 0.58 on Monday. Vernalis plc has a 12 month low of $0.47 and a 12 month high of $0.95. The stock has a 50 day moving average of $0.58 and a 200 day moving average of $0.61. The firm’s market cap is $152.64 million.

About Vernalis plc

Vernalis plc is a commercial-stage pharmaceutical company. The Company is engaged in the research, development and commercialization of pharmaceutical products. The Company operates through two segments: Commercial, which covers all areas relating to the commercial sale of pharmaceutical products, the manufacture and distribution directly related to that activity, and Research and Development, which includes all activities related to the research and development of pharmaceutical products for a range of medical disorders.

Get a free copy of the Zacks research report on Vernalis plc (VNLPY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Vernalis plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vernalis plc and related companies with MarketBeat.com's FREE daily email newsletter.